The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu. This funding, announced Friday by Moderna, builds on the $176 million it received from HHS last year to support earlier stages of vaccine research. Moderna’s vaccine is designed… read on > read on >







